331 related articles for article (PubMed ID: 11263929)
1. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
Brown GJ; St John DJ; Macrae FA; Aittomäki K
Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
[TBL] [Abstract][Full Text] [Related]
2. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
[TBL] [Abstract][Full Text] [Related]
3. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome.
Lu KH; Dinh M; Kohlmann W; Watson P; Green J; Syngal S; Bandipalliam P; Chen LM; Allen B; Conrad P; Terdiman J; Sun C; Daniels M; Burke T; Gershenson DM; Lynch H; Lynch P; Broaddus RR
Obstet Gynecol; 2005 Mar; 105(3):569-74. PubMed ID: 15738026
[TBL] [Abstract][Full Text] [Related]
4. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
Zhang YZ; Sheng JQ; Li SR; Wu ZT
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
[TBL] [Abstract][Full Text] [Related]
5. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
[TBL] [Abstract][Full Text] [Related]
6. Second primary cancers after sporadic and familial colorectal cancer.
Hemminki K; Li X; Dong C
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):793-8. PubMed ID: 11440965
[TBL] [Abstract][Full Text] [Related]
7. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.
Watson P; Bützow R; Lynch HT; Mecklin JP; Järvinen HJ; Vasen HF; Madlensky L; Fidalgo P; Bernstein I;
Gynecol Oncol; 2001 Aug; 82(2):223-8. PubMed ID: 11531271
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer.
Vasen HF; Watson P; Mecklin JP; Jass JR; Green JS; Nomizu T; Müller H; Lynch HT
Anticancer Res; 1994; 14(4B):1675-8. PubMed ID: 7979205
[TBL] [Abstract][Full Text] [Related]
9. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
[TBL] [Abstract][Full Text] [Related]
10. The results of gynecologic surveillance in families with hereditary nonpolyposis colorectal cancer.
Ketabi Z; Gerdes AM; Mosgaard B; Ladelund S; Bernstein I
Gynecol Oncol; 2014 Jun; 133(3):526-30. PubMed ID: 24631699
[TBL] [Abstract][Full Text] [Related]
11. Screening and prevention of hereditary gynecologic cancers.
Kehoe SM; Kauff ND
Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
[TBL] [Abstract][Full Text] [Related]
12. Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.
Park YJ; Shin KH; Park JG
Clin Cancer Res; 2000 Aug; 6(8):2994-8. PubMed ID: 10955776
[TBL] [Abstract][Full Text] [Related]
13. Gynecologic malignancies in Ashkenazi families with the MSH2 A636P founder mutation.
Lavie O; Gruber SB; Lejbkowicz F; Dishon S; Rennert G
Am J Obstet Gynecol; 2008 Aug; 199(2):148.e1-3. PubMed ID: 18674656
[TBL] [Abstract][Full Text] [Related]
14. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
[TBL] [Abstract][Full Text] [Related]
15. Should we colonoscope women with gynecologic cancer?
Rex D
Am J Gastroenterol; 2000 Mar; 95(3):812-3. PubMed ID: 10710083
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
Bernstein IT; Bisgaard ML; Myrhøj T
Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
[TBL] [Abstract][Full Text] [Related]
17. Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma.
Collins V; Meiser B; Gaff C; St John DJ; Halliday J
Cancer; 2005 Jul; 104(2):273-81. PubMed ID: 15948171
[TBL] [Abstract][Full Text] [Related]
18. Frequency and type of colorectal tumors in asymptomatic high-risk individuals in families with hereditary nonpolyposis colorectal cancer.
Ponz de Leon M; Della Casa G; Benatti P; Percesepe A; di Gregorio C; Fante R; Roncucci L
Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):639-41. PubMed ID: 9681535
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations and MSI status in primary, synchronous, and metachronous tumors in a family with hereditary nonpolyposis colorectal cancer (HNPCC).
González-Aguilera JJ; Nejda N; Fernández FJ; Medina V; González-Hermoso F; Barrios Y; Moreno Azcoita M; Fernández-Peralta AM
Am J Clin Oncol; 2003 Aug; 26(4):386-91. PubMed ID: 12902892
[TBL] [Abstract][Full Text] [Related]
20. Confirming a diagnosis of hereditary colorectal cancer: the impact of a Familial Bowel Cancer Registry in New Zealand.
James P; Parry S; Arnold J; Winship I
N Z Med J; 2006 Sep; 119(1242):U2168. PubMed ID: 16998569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
